Home > Research > Browse

Results for growth factor

Publications & Outputs

  1. Electroresponsive Silk-Based Biohybrid Composites for Electrochemically Controlled Growth Factor Delivery

    Magaz, A., Ashton, M., Hathout, R., Li, X., Hardy, J. & Blaker, J., 7/08/2020, In : Pharmaceutics. 12, 8, 12 p., 742.

    Research output: Contribution to journalJournal article

  2. A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease

    Yuan, Z., Li, D., Feng, P., Xue, G., Ji, C., Li, G. & Hölscher, C., 5/10/2017, In : European Journal of Pharmacology. 812, p. 82-90 9 p.

    Research output: Contribution to journalJournal article

  3. D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation

    Li, Y., Liu, W., Li, L. & Holscher, C., 15/02/2017, In : European Journal of Pharmacology. 797, p. 162-172 11 p.

    Research output: Contribution to journalJournal article

  4. A novel dual-glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist is neuroprotective in transient focal cerebral ischemia in the rat

    Han, L., Holscher, C., Xue, G., Li, G. & Li, D., 6/01/2016, In : NeuroReport. 27, 1, p. 23-32 10 p.

    Research output: Contribution to journalJournal article

  5. Neuroprotective effects of glucose-dependent insulinotropic polypeptide in Alzheimer's disease

    Ji, C., Xue, G-F., Li, G., Li, D. & Holscher, C., 01/2016, In : Reviews in the Neurosciences. 27, 1, p. 61-70 10 p.

    Research output: Contribution to journalJournal article

  6. Prophylactic liraglutide treatment prevents amyloid plaque deposition, chronic inflammation and memory impairment in APP/PS1 mice

    McClean, P. L., Jalewa, J. & Holscher, C., 15/10/2015, In : Behavioural Brain Research. 293, p. 96-106 11 p.

    Research output: Contribution to journalJournal article